Microbial biotechnology & synthetic microbiology focuses on engineering microorganisms to serve as efficient biological factories for sustainable production of fuels, chemicals, enzymes, and pharmaceuticals. By designing and rewiring metabolic pathways, scientists are enabling bacteria, yeast, and fungi to perform specialized biosynthetic tasks beyond their natural capabilities. In Synthetic Microbiology, modular genetic parts, CRISPR tools, and synthetic circuits are utilized to construct programmable microbes that respond to environmental signals, self-regulate, or produce novel compounds. These engineered strains are being applied in bioremediation, agriculture, material synthesis, and healthcare. Microbial Biotechnology & Synthetic Microbiology also support the development of microbial consortia for complex bioconversions and synthetic ecosystems. This growing discipline is pivotal to a future where microorganisms are tailored for precise industrial, medical, and environmental applications with minimal ecological impact.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain